Aportes trasnacionales de la Epigenética a la Prevención de la DM2

52. Burdge GC, Slater-Jefferies J, Torrens C, Phillips ES, Hanson MA, Lillycrop KA, et al. Dietary protein restriction of pregnant rats in the F generation induces altered methylation of hepatic gene promoters in the adult male offspring in the F1 and F2 generations. Br J Nutr. 2007; 97(3):435-9.
53. Jimenez-Chillaron JC, Isganaitis E, Charalambous M, Gesta S, Pentinat-Pelegrin T, Faucette RR, et al. Intergenerational transmission of glucose intolerance and obesity by In útero underntrition in mice. Diabetes. 2009; 58(2): 460-8.
54. Painter RC, Osmond C, Gluckman P, Hanson M, Phillips DI, Roseboom TJ, et al. Transgenerational effects of prenatal exposure to the Dutch famine on neonatal adiposity and health in later life. BJOG 115(10):1243-9.
55. Rueda-Clausen C, Silva F, Lopez-Jaramillo P. Epidemic of obesity and overweigh in Latin America and the Caribbean. Int J Cardiol 2008; 125(1):111-2.
56. Hubert HB, FeinleibM, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67(5): 968–77.
57. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005; 366(9497):1640- 9.
58. CNW Group. First Large Scale International Primary Care Study Confi rms a High Waist Circumference is Independentiy Associated with Cardiovascular Disease.Available at: https://www.newswire.ca/ en/ info/about.cgi. Accessed January 16, 2010.
59. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on (Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)) JAMA. 2001; 285(19):2486-97.
60. Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN, et al. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care. 2006; 29(2):404-9.
61. Alberti KG, Zimment P, Shaw J. The metabolic syndrome – a new worldwide defi nition. Lancet 2005; 366(9491):1059-62.
62. López-Jaramillo P, Rueda-Clausen CF, Silva FA. The utility of different defi nitions of metabolic syndrome in Andean population. Int J Cardiol. 2007; 116(3):421-2.
63. Misra A, Vikram NK, Gupta R, et al. Waist circumference cut off points and action levels for Asian Indians for identifi cation of abdominal obesity. Int J Obes (Lond)2006;30 (1):106-111.
64. Velasquez-Melendez G, Kac G, Valente JG, Tavares R, Silva CQ, Garcia ES, et al. Evaluation of waist circumference to predict general obesity and arterial hypertension in women in Greater Metropolitan Belo Horizonte, Brazil. Cad Saude Publica. 2002; 18(3):765-71.
65. Berber A, Gómez-Santos R, Fanghänel G, Sánchez- Reyes L, et al. Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican population, Int J Obes Relat Metab Disord. 2001;25(12):1794-9.
66. Pérez M, Casas JP, Cubillos-Garzón LA, Serrano NC, Silva F, Morillo CA, et al. Using waist circumference as a screening tool to identify Colombian subjects at cardiovascular risk. Eur J Cardiovasc Prev Rehabil. 2003;10(5):328-35.
67. García RG, Cifuentes AE, Caballero RS, Sanchez L, López-Jaramillo P, et al. A proposal for an appropriate central obesity diagnosis in Latin American population. Int J Cardiol. 2006;110(2):263-4.
68. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000;11(8):327-32.
69. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW, et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004; 145(5):2273-82.
70. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by gluco-corticoid. J Clin Endocrinol Metab. 1998; 83 (3):847-850.
71. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic infl ammation in obese humans. Diabetes. 2007;56(4):1010-3.
72. Accini L. Sotomayor A, Trujillo F, Barrera JG, Bautista L, López-Jaramillo P. Colombian Study to Assess the Use of Noninvasive Determination of Endothelium-Mediated Vasodilatation (CANDEV). Normal Values and Factors Associated. Endothelium. 2007;8(2):157-66.
73. Ross R. Atherosclerosis, an infl ammatory disease. N Engl J Med.1999; 340(2):115-26.
74. Bogaty P, Poirier P, Simard S, Boyer L, Solymoss S, Dagenais GR, et al. Biological profi les in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina. Circulation. 2001; 103(25):3062-8.
75. Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao Al. Is Creactive protein an independent risk factor for essential hypertension?. J Hypertens. 2001; 19(5):857-61.
76. Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Etevated C-reactive protein and pro-infl ammatory cytokines in Andean women with pre-eclampsia. Int J Gynaecol Obstet. 2001;75(3):243-9.
77. García RG, Celedón J, Sierra-Laguado J, Alarcon MA, Luengas C, Silva F, et al. Raised C reactive protein and impaired fl ow-mediated vasodilation precede the development of preeclampsia. Am J Hypertens. 2007; 20(1):98-103.
78. García RG, Pérez M, Maas R, Schwedhelm E, Böger RH, López-Jaramillo P. Plasma concentrations of asymmetric dimethylarginine (ADMA) in metabolic syndrome. Int J Cardiol 2007; 122(2):176-8.
79. Okosun IS, Liao Y, Rotimi CN, Prewitt TE, Cooper RS. Abdominal adiposity and clustering of multiple metabolic syndrome in white, black and Hispanic americans. Ann Epidemiol. 2000; 10(5):263-70.
80. Chambers JC, Eda S, Bassett P, Karim Y, Thompson SG, Gallimore JR, et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation. 2001; 104(2):145-50.
81. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifi able risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-52.
82. Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, et al. Risk factors for acute myocardial infarction in Latin America: the INTER- HEART Latin American study. Circulation. 2007;115(9):1067-74.
83. Kabagambe EK, Baylin A, Campos H. Nonfatal acute myocardial infarction in Costa Rica: modifi able risk factors, population-attributable risks, and adherence to dietary guidelines. Circulation. 2007; 115(9):1075-81.
84. Meigs JB,Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med.2008; 359(21):2208-19.
85. Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T et al. Clinical risk factors, DNA variants and the development of type 2 diabetes. N Eng J Med 2008; 359(21):2220-32.
86. Lillycrop KA, Phillips ES, Jackson AA, Hanson MA, Burdge GC, et al. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modifi cation of hepatic gene 87. expression in the offspring. J Nutr.2005; 135(6):1382- 6.
88. Vickers MH, Gluckman PD, Coveny AH, Hofman PL, Cutfi eld WS, Gertler A, et al. Neonatal leptin treatment reverses developmental programming. Endocrinology. 2005;146(10):4211-6.
89. Lawlor DA, Smith GD, O’Callaghan, Alati R, Mamun AA, Williams GM, Me al. Epidemiologic evidence for the fetal overnutrilion hypolhesis: fi ndings from the mater-university study of pregnancy and its outcomes. Am J Epidemiol. 2007;165(4):418-24.
90. Waterland RA, Travisano M, Tahiliani KG, Rached MT, Mirza S. Methyl donor supplementation prevents transgenerational ampiifi cation of obesity. Int J Obes (Lond.).2008;32(9):13



Por favor ingrese su comentario!